Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Oxford University Press
2019
|